BioNexus Gene Lab Corp. (BGLC) vs Creative Global Technology Holdings Limited Ordinary Shares (CGTL)

A side-by-side comparison of BioNexus Gene Lab Corp. and Creative Global Technology Holdings Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BGLC vs CGTL

growth of $100 · dividends reinvested · last 2y
BGLC -47.5% (-27.6%/yr)CGTL -93.6% (-74.7%/yr)BGLC compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$52$6
BGLC CGTL

BGLC vs CGTL: by the numbers

  • •CGTL is the larger company ($6M vs $3M market cap).
  • •Both run net losses; CGTL's is the smaller (-63.21% vs -82.36% net margin).

Metrics side by side

Valuation

MetricBGLCCGTL
P/S ratio0.93N/A
P/B ratio0.373.22

Profitability

MetricBGLCCGTL
Gross margin11.64%10.81%
Operating margin-42.54%-62.22%
Net margin-82.36%-63.21%
ROE-33.11%-73.98%
ROIC-32.71%-72.75%

Growth (annualized)

MetricBGLCCGTL
Revenue CAGR (5Y)-31.68%N/A
Total return CAGR (5Y)-61.00%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.